Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Accounts Payables (2021 - 2025)

Lucid Diagnostics' Accounts Payables history spans 5 years, with the latest figure at $970000.0 for Q4 2025.

  • For Q4 2025, Accounts Payables fell 21.84% year-over-year to $970000.0; the TTM value through Dec 2025 reached $970000.0, down 21.84%, while the annual FY2025 figure was $970000.0, 21.84% down from the prior year.
  • Accounts Payables reached $970000.0 in Q4 2025 per LUCD's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $4.5 million in Q1 2022 to a low of $26000.0 in Q4 2023.
  • Average Accounts Payables over 5 years is $1.8 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Accounts Payables: tumbled 97.54% in 2023, then soared 4673.08% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $1.1 million in 2021, then fell by 5.12% to $1.1 million in 2022, then crashed by 97.54% to $26000.0 in 2023, then skyrocketed by 4673.08% to $1.2 million in 2024, then dropped by 21.84% to $970000.0 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's Accounts Payables are $970000.0 (Q4 2025), $2.3 million (Q3 2025), and $833000.0 (Q2 2025).